APA (7th ed.) Citation

T, W., D, R., M, D., C, S., J, B., E, P., . . . B, L. (2025). Challenging CDKN2A assessment in BRAF-altered gliomas: Lessons from a pleomorphic xanthoastrocytoma-enriched cohort. Acta neuropathologica communications, 13(1), 170. https://doi.org/10.1186/s40478-025-02089-7

Chicago Style (17th ed.) Citation

T, Wolf, et al. "Challenging CDKN2A Assessment in BRAF-altered Gliomas: Lessons from a Pleomorphic Xanthoastrocytoma-enriched Cohort." Acta Neuropathologica Communications 13, no. 1 (2025): 170. https://doi.org/10.1186/s40478-025-02089-7.

MLA (9th ed.) Citation

T, Wolf, et al. "Challenging CDKN2A Assessment in BRAF-altered Gliomas: Lessons from a Pleomorphic Xanthoastrocytoma-enriched Cohort." Acta Neuropathologica Communications, vol. 13, no. 1, 2025, p. 170, https://doi.org/10.1186/s40478-025-02089-7.